Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity.

Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. Abstract Text:

V Roumy,G Garcia-Pizango,A-L Gutierrez-Choquevilca,L Ruiz,V Jullian,P Winterton,N Fabre,C Moulis,A Valentin,V Roumy,G Garcia-Pizango,A-L Gutierrez-Choquevilca,L Ruiz,V Jullian,P Winterton,N Fabre,C Moulis,A Valentin,

Indigenous Quechua and Mestizo populations from distinct areas in Loreto, Peru, were interviewed about traditional medication for the treatment of malaria. An ethnographic survey concerning the native theory of illness aetiology in the specific case of malaria permitted the elaboration of an efficient ethnopharmacological enquiry. The survey took place on three main zones corresponding to villages on the Napo and the Pastaza rivers (for the Quechua), and in the surroundings of Iquitos (for the Mestizos) and led to the collection of 14 plants. Serial extractions in hexane, dichloromethane, and methanol were performed on the different parts of the plants collected. The extracts were then tested for antiplasmodial activity in vitro. Seven plants displayed antiplasmodial activity (IC(50) from 2 to 25 microg/mL) and usually low cytotoxicity, indicating their antiplasmodial specificity. The results give scientific validation to the traditional medical knowledge of Quechua and Mestizo populations from Loreto and confirm a source of potentially active plants.

Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. Publishing Authors By Initials

V Roumy,G Garcia-Pizango,AL Gutierrez-Choquevilca,L Ruiz,V Jullian,P Winterton,N Fabre,C Moulis,A Valentin,V Roumy,G Garcia-Pizango,AL Gutierrez-Choquevilca,L Ruiz,V Jullian,P Winterton,N Fabre,C Moulis,A Valentin,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of ethnopharmacology

VOLUME: 112

Page Numbers: 482-9

Journal Abbreviation:

ISSN: 0378-8741

DAY: 24

MONTH: 04

YEAR: 2007

Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7903310

Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity.

AFFILIATION: Laboratoire Pharmacochimie des Substances Naturelles et Pharmacophores Redox, UMR 152 IRD-Université, Faculté des Sciences Pharmaceutiques, Toulouse, France. roumyvincent@yahoo.fr

Country: Ireland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Ethnopharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity Related Publications

• Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity.
• By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
• Changes in ultrasound morphology of the uterus and ovaries during the menopausal transition and early postmenopause: a 4-year longitudinal study.
• Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species.
• Contribution of morphological assessment of the vessel tree by three-dimensional ultrasound to a correct diagnosis of malignancy in ovarian masses.
• Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
• Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses?
• Gray-scale ultrasound morphology in the presence or absence of intrauterine fluid and vascularity as assessed by color Doppler for discrimination between benign and malignant endometrium in women with postmenopausal bleeding.
• Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor.
• Imaging in gynecological disease.
• Imaging of gynecological disease (2): clinical and ultrasound characteristics of Sertoli cell tumors, Sertoli-Leydig cell tumors and Leydig cell tumors.
• Line strengths and self-broadening parameters of the 12C 16O2 (10 1) (10 0) II transition.
• Miscarriage after a normal scan at 12-14 gestational weeks in women at low risk of carrying a fetus with chromosomal anomaly according to nuchal translucency screening.
• OC127: Two-dimensional (2D) or three-dimensional (3D) hydrosonography for discrimination between benign and malignant endometrium in women with postmenopausal bleeding?
• OC128: Agreement of two-dimensional (2D) and three-dimensional (3D) hydrosonography with hysteroscopy regarding number, regularity and localization of intracavitary focal lesions.
• OC154: Accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses.
• OC196: The contribution of CNTI-SonoVue in the classification of adnexal masses as benign or malignant: a multicenter study.
• OC204: Analysis of sonographic and Doppler features of struma ovarii: insights into a diagnostic dilemma.
• OC228: Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor.
• OC56: Miscarriage after a normal scan at 12-14 gestational weeks in women at low risk of carrying a fetus with chromosomal anomaly according to nuchal translucency screening.
• Pilot study of an EST approach of the coccolithophorid Emiliania huxleyi during a virus infection.
• The role of the dentist at crime scenes.
• Ultrasound assessment of endometrial morphology and vascularity to predict endometrial malignancy in women with postmenopausal bleeding and sonographic endometrial thickness >or= 4.5 mm.
• [A broad approach to the ilio-lumbar region]
• [Cadmium content of whole blood of inhabitants from various regions of Bavaria]
• [Favorable experience with hyaluronidase in obstetrics and gynecology.]
• [Field study of workers with longterm exposure to calcium cyanamide (author's transl)]
• [Nickel and chromium content of selected human organs and body fluids]
• [Pulmonary fibrosis caused by hard-metal dusts]
• [RESULTS OF TRUNCAL MEDIAN AND ULNAR NERVE REPAIRS.]